Astrazeneca’s Dapagliflozin gets DCGI nod for treatment of heart failure EP News Bureau Jul 4, 2020 Dapagliflozin (Forxiga) is an SGLT-2 inhibitor that can reduce the risk of cardiovascular death and hospitalisation for heart…
